Vatech America, Inc.
$144.9K 30 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Citieffe, Inc.
Citieffe, Inc. reported $145,388.52 across General Payments, Research, and Ownership to 42 physicians and teaching hospitals across 42 transactions.
- $145.4K Below-median payer
- All-tracks total
- 42 Below-median volume
- Transactions
- 42 Below-median reach
- Recipients
- +$77.1K
- General Payments vs PY2023
Citieffe, Inc. reported $145,388.52 across all CMS Open Payments tracks (General + Research + Ownership) to 42 physicians and teaching hospitals in Program Year 2024 - ranking #1087 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $145,388.52, averaging $3.5K per recipient.
How Citieffe, Inc.'s $145.4K all-tracks total breaks down
Citieffe, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer citieffe-inc Citieffe, Inc.
$145.4K · #1087/1,925 · 0.0% industry · PY2024
- TOT $145.4K
- RANK #1087
- SHARE 0.0%
- TXN 42
- RCP 42
- CAT 4
- GEN $145.4K
- ΔGEN +$77.1K
- TOP1 36.6%
- PY 2024
Volume peers
Nearest volume peer: Vatech America, Inc. ($144.9K)
Citieffe, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Citieffe, Inc.'s CMS-reported General Payments increased by $77.1K (+112.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CITIEFFE, INC.PY2023: CITIEFFE, INC.PY2024: Citieffe, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $68,286.15
- PY2024
- $145,388.52
What the Data Shows for Citieffe, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Citieffe, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $113.1K, accounting for 77.8% of this company's General Payments and 29 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Citieffe, Inc.'s 4-category general-payment breakdown at $113.1K, 77.8% of the reported total.
Citieffe, Inc. reports 4 general-payment categories - the top three are Consulting Fee (77.8%), Travel and Lodging (18.4%), and Royalty or License (2.4%). The remaining 1 category make up 1.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Citieffe, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $113.1K | 29 | 77.8% |
| Travel and Lodging | $26.8K | 8 | 18.4% |
| Royalty or License | $3.5K | 4 | 2.4% |
| Education | $2.0K | 1 | 1.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $104,778.52 (72.1%) of $145,388.52 in this company's General Payments records across 14 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Citieffe, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Andrew Hiller
$53,145.89 across 7 reported transactions
- 2
Diego Lopes de Lima
$16,760.00 across 5 reported transactions
- 3
Brian Bacot
$12,922.63 across 6 reported transactions
- 4
Ross Stone
$12,500.00 across 3 reported transactions
- 5
Curtis Kephart
$9,450.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Citieffe, Inc.'s spend rank (#1087 of 1,925, bottom 44% by spend) and concentration rank (#795 of 1,838, top 43% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Avid Radiopharmaceuticals, Inc. : $8.1K total payments, HHI 1793
- Applied Medical Technology Inc : $176.9K total payments, HHI 1791
- Ignite Orthopedics, LLC : $705.4K total payments, HHI 1790
- BioPro, Inc. : $101.9K total payments, HHI 1788
- Lazarus 3D : $1.2K total payments, HHI 1788
- exocad America, Inc. : $54.9K total payments, HHI 1781
- Citieffe, Inc. (this company) : $145.4K total payments, HHI 1775
- Diagnostica Stago, Inc : $49.4K total payments, HHI 1775
- Cerus Corporation : $405.7K total payments, HHI 1771
- Brixton Biosciences, Inc. : $36.4K total payments, HHI 1756
- Sysmex America, Inc. : $54.4K total payments, HHI 1755
- bluebird bio, Inc. : $208.3K total payments, HHI 1750
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Citieffe, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Citieffe, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Citieffe, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Argon Medical Devices, Inc.
$147.3K 1,135 recipients
Compare payment profiles
Accuray Incorporated
$143.0K 278 recipients
Compare payment profiles
Nordic Pharma, Inc.
$142.6K 166 recipients
Compare payment profiles
Benco Dental Supply Co.
$148.4K 1,359 recipients
Compare payment profiles
Archimmune Therapeutics Inc.
$142.0K 1 recipients
Compare payment profiles
Put this to use
Citieffe, Inc. ranks #1087 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Citieffe, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.